47 岁的 Michelle Williams 和 71 岁的 Gill Rich 患有罕见的自身免疫性肝病 PBC，他们在最近批准的治疗 Elafibranor 中找到了希望。 47-year-old Michelle Williams and 71-year-old Gill Rich, affected by rare autoimmune liver disease PBC, find hope in recently approved treatment Elafibranor.
Michelle Williams(47岁)和Gill Rich(71岁)是受初等血栓炎(PBC)影响的人,这是一种罕见的自发性免疫性肝病,经常被误诊,特别是在妇女中。 Michelle Williams, 47, and Gill Rich, 71, are among those affected by primary biliary cholangitis (PBC), a rare autoimmune liver disease that often goes misdiagnosed, particularly in women. 皮血球会损害胆道,并可能导致肝功能衰竭. PBC damages bile ducts and can lead to liver failure. 联合王国有大约25 000例病例,最近核准的新治疗Elafibranor(Elafibranor)有望改善管理,特别是对不适应标准疗法的病人而言。 With around 25,000 cases in the UK, recent approval of Elafibranor, a new treatment, offers hope for improved management, especially for patients unresponsive to standard therapies. 妇女都倡导提高认识和支持。 Both women advocate for awareness and support.